Sinclair swine develop an aggressive form of melanoma, which, in many cases, spontaneously regresses after a complete metastatic phase. We used Affymetrix GeneChip R Porcine Genome Arrays consisting of 24 123 probe sets to compare gene expression in white blood cells (WBCs) and various tissues including the liver, lungs, inguinal lymph nodes and spleen harvested from a Sinclair piglet afflicted by melanoma at birth and exhibiting metastatic lesions at weaning (6 weeks) with those from a full-sibling piglet that showed no incidence of melanoma at birth and weaning. The highest number (3489; ,14%) of significantly upregulated transcripts (fold change in gene expression >2.0 and t-test P-value r0.05) was observed in the liver, while the spleen exhibited the lowest number of upregulated transcripts (528; ,2%). Among significantly downregulated genes, the highest numbers were observed in the inguinal lymph nodes (3651; ,15%) and the least in WBCs (730; ,3%). Differentially expressed transcripts included genes involved in melanoma pathogenesis including SILV, TYR and RAB28. SILV was over-expressed 784-, 430-and 164-fold, while TYR was over-expressed 138-, 81-and 28-fold in the liver, lungs and inguinal lymph nodes, respectively. Quantitative real-time RT-PCR (qRT-PCR) confirmed the microarray data of 12 selected differentially expressed sequences. These results suggest that significant changes in gene expression occur during metastasis of malignant melanoma in the Sinclair swine model. In addition, qRT-PCR analysis of the above 12 differentially expressed sequences was carried out on liver samples collected from 22 pigs (12 of which had melanoma during the first 6 weeks of life), and an ANOVA test contrasting absolute RNA expression between pigs with regressing, progressing and without tumors was significant for TYR, TACSTD1, MATP, GPNMB and CYP4A22, with P-values of 0.034, 0.015, 0.007, 0.050 and 0.022, respectively.
Introduction
The Sinclair Miniature Pig Melanoma model was established in the 1970s by breeding melanoma-bearing pigs to establish a line with up to 70% incidence of melanoma (Hook et al., 1979; Tissot et al., 1987) . Melanoma in Sinclair swine usually develops in utero or within the first 6 weeks of life (Gomez-Raya et al., 2007) , with lesions varying from benign flat nevi to large, deeply invasive, exophytic tumors possessing characteristics of malignant tumors (Das Gupta et al., 1989) as well as some in vitro characteristics of benign neoplastic cells found in childhood tumors such as retinoblastoma or neuroblastoma that are of neural or neural crest tissue origin as are melanocytes. Cutaneous malignant melanoma in Sinclair swine may have multiple primary sites and usually disseminates in the lymph nodes and visceral organs (Das Gupta et al., 1989; Greene et al., 1994; Greene et al., 1997) . Some pigs may die because of widespread disease but a majority develop a cell-mediated immune response that causes complete regression of the tumors (Misfeldt and Grimm, 1994; Greene et al., 1997) , although the immune response also attacks melanocytes in the skin, resulting in varying degrees of vitiligo that may progress to complete depigmentation (Misfeldt and Grimm, 1994) .
Gene expression analysis using DNA microarrays allows the simultaneous monitoring of differential gene expression for thousands of genes in biological samples (Eisen and Brown, 1999) . Microarray gene expression analysis provides a fresh insight into the genetic basis of cancer initiation and progression (Luo et al., 2001; Hoek et al., 2004; Talantov et al., 2005) and -E-mail: gomez.luis@inia.es identification of genes that may be of prognostic value (Wang et al., 2004; Barrier et al., 2005) as well as genes that may be associated with aggressive tumor behavior (Bittner et al., 2000) . In addition, microarray gene expression profiling has shown promise in evaluating the sensitivity of tumors to chemotherapy or other targeted approaches to therapy (Huang and Sadee, 2003; Mariadason et al., 2003; Alaoui-Jamali et al., 2004; Clarke et al., 2004) . There are no data on gene expression changes in melanoma regression. However, Sinclair swine is a unique model for investigating molecular changes during regression, given their high frequency of cancer regression.
This study hypothesizes that genes are differentially expressed in Sinclair swine with melanoma compared with those not afflicted by the disease. The study also hypothesizes that genes are differentially expressed in melanoma v. non-melanoma pigs during tumor progression and regression. The main objective of this study was to investigate the expression profiles of genes that are modulated during development and metastasis of malignant melanoma in Sinclair swine at 6 weeks using an Affymetrix GeneChip R Porcine Genome Array (Affymetrix Inc., Santa Clara, CA, USA) and quantitative real-time RT-PCR (qRT-PCR), with the goal of improving the understanding of melanoma progression at molecular and gene-expression levels. This study also investigates gene expression at later ages, in an effort to gain further knowledge of the molecular changes that occur during the process of tumor progression and regression in Sinclair swine.
Material and methods

Animals
The Sinclair melanoma swine were derived from a herd maintained at the University of Nevada, Reno Agricultural Experiment Station. They were maintained under animal care and use protocols of the University of Nevada, Reno. The experimental piglets, one female afflicted with melanoma at birth, and its full female sibling that showed no incidence of melanoma at birth and at weaning, were sacrificed at 6 weeks (weaning age). Before euthanasia, the live piglets were bled by jugular venipuncture using a 20-gauge needle. A volume of 5 ml peripheral whole blood was collected in vacutainer tubes containing EDTA anticoagulant (Becton Dickinson Biosciences; Franklin Lakes, NJ, USA). Blood samples were spun in a centrifuge at 3000 3 g for 15 min to separate buffy coats containing white blood cells (WBCs), which were stored in liquid nitrogen.
Euthanasia was conducted using sodium pentobarbital at a dosage of 1 ml/10 lb body weight. The post-mortem examination showed that the piglet afflicted by melanoma at birth had numerous metastatic lesions infiltrated into the internal visceral organs and lymph nodes ( Figure 1 and Table 1) while the other piglet had no evident metastatic tumors. For the melanoma-afflicted pig, samples were collected from the lymph nodes and internal visceral organs that were infiltrated by tumors including the liver, lungs, spleen, kidneys, pancreas, stomach, small intestines and colon (Table 1) . Only sections of the melanoma-afflicted tissues that exhibited almost 100% melanoma lesions were collected to minimize the presence of non-melanoma tissues in the sample. For the pig without melanoma, samples were obtained from equivalent lymph nodes and internal visceral organs, respectively. The harvested tissues were stored in liquid nitrogen in readiness for RNA extraction.
Of note, skin samples with or without tumors were also collected from both piglets, respectively, but the quality of RNA extracted from samples with tumors was very low, because of the presence of high amounts of dead tissue. Consequently, skin samples were not included in the microarray and qRT-PCR analysis in this study.
RNA isolation
Total RNA was isolated from lungs, liver, inguinal lymph nodes, spleen and WBCs harvested from melanoma-afflicted and normal control pigs, respectively, using the Qiagen RNeasy mini kit (Qiagen Inc., Valencia, CA, USA) according to the manufacturer's instructions. RNA quantity and quality were determined by capillary electrophoresis using the Agilent 2100 Bioanalyzer (Agilent Technologies; Santa Clara, CA, USA) according to the manufacturer's instructions.
Microarray hybridization and data analysis Labeled cDNA was prepared from total RNA and hybridized with the high-density oligonucleotide Affymetrix GeneChip R Porcine Genome Array (Affymetrix Inc.) consisting of 24 123 probe sets, according to standard manufacturer protocols. Arrays were scanned using Affymetrix protocols and scanners. For subsequent analysis, each of the ten hybridized arrays (five with melanoma and five with normal cDNA, respectively) was considered as an experimental sample, and each probe set on the array was considered as a separate gene. Microarray data acquisition and image analysis was performed using Affymetrix GeneChip R Operating Software (GCOS). GeneSpring 7.0 software (Agilent Technologies; Santa Clara, CA, USA) was used to normalize and analyze the GCOS output data to provide expression values for each gene. Gene names and accession numbers were updated according to the annotated version of the Affymetrix Porcine GeneChip R (Tsai et al., 2006) . Genes with expression values >2.0 (upregulated >2.0-fold) or expression values <0.5 (downregulated >2.0-fold) in at least one out of the 10 experimental samples were selected for further analysis, and a total of 20 177 genes (,84%) fulfilled this criterion. Genes selected for further analysis were classified into functional subgroups using Simplified Ontology, a feature of GeneSpring.
qRT-PCR qRT-PCR was performed to validate the microarray data of 12 selected genes that were differentially expressed (up-or downregulated) in the melanoma compared with normal samples (Table 3 ). Primers and probes were designed using the Primer Express 2.0 software (Applied Biosystems [ABI]; Foster City, CA, USA). Reverse transcription (RT) was performed with 1 mg total RNA isolated from lungs, liver, inguinal lymph nodes, spleen and WBCs harvested from melanoma-afflicted and normal control pigs, using 300 ng/ml random primers and Superscript II Reverse Transcriptase TM (Invitrogen; Carlsbad, CA, USA) according to the manufacturer's instructions. qRT-PCR was performed using the 5 0 Nuclease Taqman Assay (ABI) according to the manufacturer's instructions. In brief, 1 ml of cDNA obtained from the RT reaction were amplified in a 25 ml containing 2 3 TaqMan R Universal PCR Mastermix (ABI; Foster City, CA, USA), 900 nmol/l of forward and reverse primers and 250 nmol/l of TaqMan hybridization probe. For each sampled time point, the target gene was amplified concurrently with the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) control gene, in separate wells. Non-template controls were included in every run. All reactions were performed in triplicate. Thermal cycling was performed in an ABI PRISM 7000 Sequence Detection System unit (ABI; Foster City, CA, USA).
qRT-PCR data, comprising threshold value (Ct) values, were analyzed using the Relative Expression Software Tool (REST & ; Pfaffl et al., 2002) , which uses a mathematical model based on the PCR efficiencies and the mean Ct deviation between the sample and the control group, where the ratio R¼E Gene expression in Sinclair swine with melanoma each pig. A set of measurements were used to monitor tumor status of each piglet over time including length, width and height that were measured using a caliper. The recording of tumors was carried out weekly. Tissue samples (liver, tail, etc.) from culled animals were systematically collected and stored at 2808C for most pigs and information on those pigs was documented in a database. More information on this population and historical records can be found in Gomez-Raya et al. (2009) . In this study, length was used as a criterion for estimating tumor size based on James et al. (1999) , who concluded that unidimensional measurements for tumors are appropriate for estimating regression in solid tumors. Pigs whose tumors had reached the maximum length at collection time were considered as progressing animals. Pigs with tumors that were reduced in length (compared with the maximum registered length) at collection time were categorized as regressing animals. The average change for all tumors within each pig was used to assign piglets into progressing or regressing animals ( Table 2 ). More information on the 22 liver samples used in the analyses of gene expression is given in Table 2 . The frozen samples were used in qRT-PCR analysis of 12 genes that were upregulated during metastasis. A one-way ANOVA test was performed to test whether gene expression in piglets with regressing, progressing or without tumors was different. For this tumor regression study, the same protocols were followed for RNA extraction from liver frozen samples obtained from the additional 22 pigs described above. qRT-PCR was performed as described earlier for the 12 selected genes ( Table 3 ) that were differentially expressed in the melanoma compared with normal samples. qRT-PCR data comprising cDNA (ng) quantified for each gene were analyzed by oneway ANOVA (Minitab 15 software) contrasting absolute RNA expression for the 12 genes in the animals with melanoma (regression and progression) and without the disease.
Results
Differential gene expression in melanoma compared with normal samples
Microarray analysis compared the gene expression profiles of samples (lungs, liver, inguinal lymph nodes, spleen and WBCs) obtained from melanoma-afflicted and normal control piglets born from the same litter of Sinclair swine, at weaning. For the Gene expression in Sinclair swine with melanoma melanoma-afflicted piglet, metastatic lesions were visually observed in lungs, liver, inguinal lymph nodes and spleen from which samples were obtained (Figure 1 ). For the purpose of discussion, melanoma samples refer to those obtained from the melanoma-afflicted pig, while normal samples refer to those derived from the pig without melanoma. After microarray gene expression analysis, genes with expression values >2.0 (upregulated >2.0-fold) or expression values <0.5 (downregulated >2.0-fold) in at least one out of the 10 experimental samples (hybridized arrays) were selected for further analysis, with a total of 20 177 genes out of the original 24 123 ( , 84%) fulfilling the criterion.
Out of the originally selected 20 177 genes, a total of 7012 genes (displaying >2.0-fold induction in a particular tissue and also >2.0-fold repression in another tissue) were hierarchically clustered by Pearson's correlation using GeneSpring 7.0 software (Figure 2 ). Hierarchical clustering of gene expression values for the 7012 genes revealed two discrete gene modulation patterns: induced genes (red) and downregulated genes (green), with correlated expression of genes involved in diverse functions and cellular pathways. Hierarchical clustering also revealed a distinct separation between gene expression values for respective samples obtained from the melanoma-afflicted and non-melanoma pigs, with the exception of WBCs and spleen, where the least separation and variation of gene expression values were observed (Figure 2) . The liver and inguinal lymph nodes exhibited the greatest separation and variation of gene expression values between melanoma and the non-melanoma pigs, followed by the lungs.
To determine differential gene expression ratios, the gene expression values for samples obtained from the melanomaafflicted pig were divided by gene expression values for the corresponding samples derived from the animal without melanoma, for each of the selected 20 177 genes. Genes with differential gene expression ratios >2.0 (upregulated by >2.0-fold) or expression values <0.5 (downregulated by >2.0-fold) were considered as significantly induced or repressed in melanoma compared with normal samples. The liver exhibited the highest number of differentially expressed genes (3489) that were significantly upregulated >2.0-fold in melanoma compared with normal samples (Table 4) , while the spleen exhibited the least (528). Of the significantly downregulated genes, the inguinal lymph node exhibited the Figure 2 Hierarchical clustering of 7012 genes that were modulated (up-or downregulated) >2-fold in at least one out of the ten experimental samples after microarray analysis. Each column represents a sample and each row is a gene. The condition gene tree shows induced genes (red) and repressed genes (green), while genes whose expression did not change are black. The color code for melanoma samples is red and normal samples are yellow. Okomo-Adhiambo, Rink, Rauw and Gomez-Raya highest number of differentially expressed genes (3651), while WBCs exhibited the least number (730). The samplespecific variation in differential gene expression between the melanoma-afflicted and normal piglets was consistent with that observed after hierarchical clustering.
Diverse functional categories of genes are modulated during melanoma progression Transcripts representing several functional categories were significantly modulated in melanoma compared with normal samples (Table 5 ). The modulated transcripts included genes directly involved in melanoma development and progression, as well as genes generally associated with cancer pathogenesis including transcription factors, signal transducers, cell cycle regulators and apoptosisrelated genes, as well as genes involved in the immune response and energy metabolism (Table 5 ). These findings suggest that numerous cellular processes were transcriptionally altered during melanoma progression, with the majority of gene modulations (up-and downregulation) occurring in the liver and inguinal lymph nodes. Table 5 shows a partial list of genes significantly modulated in melanoma compared with normal samples; a complete list of these functionally classified genes can be found in the supplemental information.
A number of genes directly associated with cancer pathogenesis were differentially expressed in melanoma compared with normal samples including SILV, TYR and RAB28 (Table 5 ). The SILV gene, which encodes melanocyte protein PMEL17, was the most highly differentially expressed gene in melanoma compared with normal samples, and was overexpressed 784-fold in the liver, 430-fold in the lungs and 164-fold in the inguinal lymph nodes, but remained unchanged in the WBCs and spleen samples (Table 5) . qRT-PCR analysis (Table 6 ) confirmed the induced expression of SILV in the liver, lungs and inguinal lymph nodes, as well as its unaltered expression in the WBCs and spleen. The TYR gene which encodes tyrosinase protein, a copper-containing oxidase enzyme that catalyzes multiple steps in melanin biosynthesis in melanocytes and melanoma cells (Tripathi et al., 1992; Battyani et al., 1993; Kwon, 1993; Perez et al., 2000) , was over-expressed by 138-fold in the liver, by 81-fold in the lungs and 28-fold in the inguinal lymph nodes after microarray analysis (Table 5) , and similar to SILV, remained unchanged in WBCs and spleen, findings that were confirmed by qRT-PCR (Table 6 ). Ras-related protein Rab-38 (RAB38 ) was induced by ,83-, 50-and 20-fold in the liver, lungs and inguinal lymph nodes with melanoma, respectively.
Genes encoding proteins associated directly with cellular transcription (Table 5 ) were among the majority of genes induced in melanoma compared with normal samples, including the proto-oncogene protein c-Fos (FOS) and the proto-oncogene c-jun (JUN). FOS, an immediate early gene expressed transiently in the G 1 phase of the cell cycle after antigen stimulation of T lymphocytes, which plays a role in cell proliferation (Ullman et al., 1990; Angel and Karin, 1991) , was significantly induced by ,3-fold in inguinal lymph nodes with melanoma, but remained unchanged in the rest of the melanoma samples. JUN, which encodes a protein that interacts directly with specific target DNA sequences to regulate gene expression (Bohmann et al., 1987) and interacts with FOS to form a dimer, was upregulated 4-fold and 3-fold in the liver and inguinal lymph nodes with melanoma, respectively.
Several genes encoding signal transduction proteins were also upregulated in the samples with melanoma including tumor-associated calcium signal transducer 1 (TACSTD1) and mitogen-activated protein kinase 3 (MAP3K2). TACSTD1, which was induced 20-fold in the liver and 22-fold in the inguinal lymph nodes with melanoma, encodes a carcinomaassociated antigen that functions as a homotypic calciumindependent cell adhesion molecule (Simon et al., 1990) . The induced expression of TACSTD1 was confirmed by qRT-PCR (Table 6 ). MAP3K2, upregulated .7-fold and .2-fold in the liver and lungs with melanoma, respectively, is a component of a protein kinase signal transduction cascade and regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7 (Cheng et al., 2000) .
Malignant melanomas show impaired ability to undergo programmed cell death (apoptosis) in response to a wide range of external stimuli, conferring them with a selective advantage for progression and metastasis as well as resistance to therapy (Ivanov et al., 2003; Gong et al., 2005; Li et al., 2005) . In this study, we observed increased transcription of anti-apoptotic genes in the melanoma compared with normal samples (Table 5) , including BCL-2, an integral outer mitochondrial membrane protein that blocks cell death by controlling mitochondrial membrane permeability and prevents translocation of pro-apoptotic caspases (Chandra et al., 2002 ) that was upregulated by 2.5-fold in melanoma compared with normal liver, but was unchanged in the rest of the samples. Apoptosis inhibitor survivin (BIRC5) was induced 2.5-fold and 2.7-fold in liver and lungs with melanoma, respectively. Bcl-2 and other inhibitors of apoptosis such as survivin are elevated in a range of human cancers including melanomas, prostate carcinoma and gliomas (LaCasse et al., 1998; Altieri, 2003; ChawlaSarkar et al., 2004) .
In contrast, genes encoding pro-apoptotic proteins were repressed (Table 5) , including DAP kinase-related apoptosisinducing protein kinase 1 (STK17A), cell cycle and apoptosis regulatory protein 1 (CCAR1), as well as p53-regulated protein PA26 (Sestrin 1; SESN1). STK17A, which encodes a serine/threonine-protein kinase 17a that acts as a positive regulator of apoptosis (Sanjo et al., 1998) , was downregulated ,6-fold in inguinal lymph nodes with malignant melanoma. CCAR1, downregulated 3-fold in inguinal lymph nodes with melanoma, mediates apoptosis induction, which involves sequestration of 14-3-3 protein(s) and altered expression of multiple cell cycle regulatory genes including MYC, CCNB1 and CDKN1A (Rishi et al., 2003) . SESN1, a potential regulator of cellular growth (Velasco-Miguel et al., 1999) , was downregulated by ,3-fold and 2-fold in melanoma liver and lungs, respectively. Gene expression values of samples obtained from the melanoma-afflicted pig were divided by those of the corresponding samples from the non-melanoma pig, to provide differential gene expression ratios. Expression ratios >2.0 (>2.0-fold upregulation) and <0.05 (>2.0-fold downregulation) are considered significant. Takaoka et al. (1998) . n Weterman et al. (1995) . o Savas et al. (2003) .
qRT-PCR analysis validated the microarray data of 12 genes that were differentially expressed (induced/repressed) or unchanged in melanoma compared with normal samples, and there was a qualitative agreement in the results of the microarray and qRT-PCR analyses (Table 6 ). The genes TYR, SILV, SPP1, MRPL28, MATP, LGALS1 and GPNMB were overexpressed (>2-fold), based on microarray and qRT-PCR analyses, in the liver, lung and inguinal lymph node samples. TACSTD1 was over-expressed based on both methods in the liver and inguinal lymph nodes, but in the lungs, it was unchanged by microarray and downregulated by qRT-PCR analysis. MCAM was upregulated in the liver, downregulated in the lungs and unchanged in the inguinal lymph nodes, while LTBP4 was upregulated in the liver and inguinal lymph nodes, but remained unchanged in the lungs, based on both methods. However, in the spleen, all 12 genes were unchanged after microarray analysis but were downregulated based on qRT-PCR, with the exception of MRPL28, while in the WBCs, all 12 transcripts showed no significant changes in expression after microarray analysis, but after qRT-PCR, at least four transcripts were upregulated by >2-fold (MRPL28, MCAM, LTBP4 and CYP4A22). Similar to the microarray findings, after qRT-PCR analysis, the liver exhibited the highest fold change differences in gene expression in melanoma compared with normal samples, followed by the inguinal lymph nodes, lungs, spleen and then WBCs. Higher differential gene expression ratios were observed between melanoma and normal samples after qRT-PCR, compared with microarray analysis, a finding consistent with earlier observations that qRT-PCR has greater detection sensitivity than microarray technology (Yuen et al., 2002) .
Gene expression during tumor progression and regression
The results of the ANOVA test contrasting absolute RNA expression for 12 genes for piglets with regressing, progressing or without tumors are shown in Table 8 . The results of the ANOVA test were significant for TYR, TACSTD1, MATP, GPNMB and CYP4A22, with P-values of 0.034, 0.015, 0.007, 0.050 and 0.022, respectively. With the exception of MATP, the other genes (TYR, TACSTD1, GPNMB and CYP4A22) were downregulated, suggesting that gene expression is under-regulated when comparing piglets with regressing v. progressing tumors. This finding is contrary to our earlier observation using animals with metastatic melanoma v. those that were disease free during the first 6 weeks of life, where TYR, TACSTD1, MATP, GPNMB and CYP4A22 were all upregulated in liver samples of animals with melanoma compared with those without the disease (Table 6 ). These results illustrate that changes in gene expression may occur in varying patterns during progression and regression of malignant melanoma.
Discussion
Our study identified genes from diverse functional classes that were differentially expressed in melanoma compared with normal tissue samples, suggesting that numerous cellular processes were transcriptionally modulated during the progression of melanoma in Sinclair swine (Table 5) . Among tissues that were tested, the inguinal lymph node and liver had the highest number of genes (6266 and 5917, respectively) that were differentially expressed between melanoma and normal cells ( Table 4 ), suggesting that these tissues are favored as predilection sites by metastatic melanocytes. The genes that were differentially expressed in this study showed >80% sequence similar to genes modulated in human melanomas (Table 7) . These molecular similarities are significant as some of the genes that were either induced or repressed in this study are used as biomarkers in human malignant melanoma. The TYR gene associated with melanoma pathogenesis and significantly upregulated in this study is expressed at various levels in human melanoma cells and is considered an important biochemical marker of melanocytes Parkhurst et al., 1998; Overwijk et al., 1999) , while the RAB28 gene, also overexpressed in this study, is expressed in melanocytes and is involved in melanosomal transport and docking (Jager et al., 2000) as well as in the proper sorting of tyrosinase-related protein 1 (TYRP1). The increased transcription of anti-apoptotic genes in this study, including BCL-2 that is elevated in a range of human cancers including melanomas, prostate carcinoma and gliomas (LaCasse et al., 1998; Altieri, 2003; Chawla-Sarkar et al., 2004) , demonstrates further the similarity in the modulation of gene expression in Sinclair swine and human cancers.
The contrasting results observed in the expression of genes tested by microarrays and qRT-PCR in liver samples obtained from 6-week-old piglets, compared with gene expression tested by qRT-PCR in the frozen liver samples collected at an older age, suggests a better developed and more mature immune system in the older piglets. The downregulation of TYR, TACSTD1, GPNMB and CYP4A22 during regression and progression of the disease at a later age may be the result of a cell-mediated response that attacks metastatic melanocytes as the animals become older (Greene et al., 1997) , and is consistent with the observation that animals with melanoma develop vitiligo with age (Misfeldt and Grimm, 1994) .
The findings in this study may facilitate further discovery of candidate genes and molecular markers that can provide a better understanding of the pathogenesis of metastatic melanoma in Sinclair swine.
